# A Study to Assess Stroke Risk Among Users of Typical Versus Atypical Antipsychotics Stratified by Broad Age Group

> **NCT04002700** · — · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 1234412 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Haloperidol
- **DRUG:** Typical Antipsychotics
- **DRUG:** Atypical Antipsychotics

## Key facts

- **NCT ID:** NCT04002700
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-06
- **Primary completion:** 2019-05-31
- **Final completion:** 2019-05-31
- **Target enrollment:** 1234412 (ACTUAL)
- **Last updated:** 2025-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04002700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04002700, "A Study to Assess Stroke Risk Among Users of Typical Versus Atypical Antipsychotics Stratified by Broad Age Group". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT04002700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*